Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update
New method of use patent covering pelareorep as an immunotherapy for cancer has been issued in several countries, with U.S. issuance expected in the near term Three patent applications are pending, including two method of use with one expected to be converted to a Track One application this quarter Company expects to add a new […]
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
